Home › Funds › Marshall Wace › ABT

Marshall Wace position in ABT

ABBOTT LABORATORIES · Health Care

Latest position (Q2 2026)5.54M sh
Reported value held$503.07M
Portfolio Weight0.40%
First reportedQ3 2021
Last changeAdd

Quarter by quarter

QuarterSharesValueChange
Q3 2021 245.55K $29.01M New
Q4 2021 1.25M $176.03M Add
Q1 2022 570.27K $67.50M Reduce
Q2 2022 31.70K $3.44M Reduce
Q1 2023 3.90K $395.42K New
Q2 2023 248.82K $27.13M Add
Q3 2023 34.05K $3.30M Reduce
Q4 2023 482.84K $53.15M Add
Q1 2024 22.80K $2.38M Reduce
Q2 2024 216.34K $22.48M Add
Q3 2024 123.23K $14.05M Reduce
Q4 2024 300.00K $33.93M Add
Q1 2025 156.94K $20.82M Reduce
Q4 2025 58.59K $7.34M New
Q1 2026 2.01M $206.46M Add
Q2 2026 5.54M $503.07M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

Other funds holding ABT

All ABT fund holders →